CSRP3 and myocardial infarction: As has been shown before, MLP oligomerization is altered in rat heart disease models, such as aortic banding and myocardial infarction, where an increase in the monomeric MLP is accompanied by a reduction in oligomeric MLP, especially the tetrameric oligomer [29,59].